Oppenheimer & Co’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-22,365
| Closed | -$1.19M | – | 1685 |
|
|
2025
Q2 | $1.19M | Sell |
22,365
-1,300
| -5% | -$66K | 0.02% | 774 |
|
|
2025
Q1 | $1.02M | Sell |
23,665
-134
| -0.6% | -$6.79K | 0.02% | 798 |
|
|
2024
Q4 | $1.34M | Sell |
23,799
-685
| -3% | -$42.6K | 0.02% | 683 |
|
|
2024
Q3 | $1.67M | Buy |
24,484
+124
| +0.5% | +$7K | 0.03% | 610 |
|
|
2024
Q2 | $1.03M | Buy |
24,360
+1,272
| +6% | +$70K | 0.02% | 763 |
|
|
2024
Q1 | $1.59M | Buy |
23,088
+401
| +2% | +$25.4K | 0.03% | 580 |
|
|
2023
Q4 | $1.68M | Buy |
22,687
+1,020
| +5% | +$66.9K | 0.03% | 547 |
|
|
2023
Q3 | $1.48M | Buy |
21,667
+32
| +0.1% | +$2.71K | 0.03% | 550 |
|
|
2023
Q2 | $2.03M | Buy |
21,635
+747
| +4% | +$58.3K | 0.04% | 472 |
|
|
2023
Q1 | $1.42M | Buy |
20,888
+263
| +1% | +$16.9K | 0.03% | 564 |
|
|
2022
Q4 | $1.02M | Sell |
20,625
-7,437
| -27% | -$304K | 0.02% | 674 |
|
|
2022
Q3 | $912K | Buy |
28,062
+5,216
| +23% | +$215K | 0.02% | 689 |
|
|
2022
Q2 | $900K | Buy |
22,846
+6,980
| +44% | +$373K | 0.02% | 723 |
|
|
2022
Q1 | $1.11M | Sell |
15,866
-3,094
| -16% | -$226K | 0.02% | 707 |
|
|
2021
Q4 | $1.48M | Sell |
18,960
-1,324
| -7% | -$117K | 0.03% | 618 |
|
|
2021
Q3 | $1.94M | Sell |
20,284
-4,156
| -17% | -$439K | 0.04% | 519 |
|
|
2021
Q2 | $3.04M | Buy |
24,440
+1,663
| +7% | +$198K | 0.05% | 394 |
|
|
2021
Q1 | $3M | Buy |
22,777
+5,978
| +36% | +$818K | 0.06% | 357 |
|
|
2020
Q4 | $2.23M | Buy |
16,799
+12,675
| +307% | +$1.53M | 0.05% | 416 |
|
|
2020
Q3 | $420K | Sell |
4,124
-8,784
| -68% | -$759K | 0.01% | 870 |
|
|
2020
Q2 | $1.12M | Buy |
12,908
+790
| +7% | +$63.1K | 0.03% | 534 |
|
|
2020
Q1 | $703K | Buy |
+12,118
| New | +$984K | 0.02% | 633 |
|
|
2019
Q3 | – | Sell |
-5,595
| Closed | -$660K | – | 1283 |
|
|
2019
Q2 | $660K | Sell |
5,595
-5,709
| -51% | -$575K | 0.02% | 723 |
|
|
2019
Q1 | $979K | Buy |
+11,304
| New | +$962K | 0.03% | 589 |
|
|
2018
Q2 | – | Sell |
-7,542
| Closed | -$304K | – | 1351 |
|
|
2018
Q1 | $304K | Buy |
+7,542
| New | +$368K | 0.01% | 1050 |
|
|
2015
Q4 | – | Sell |
-14,267
| Closed | -$256K | – | 1305 |
|
|
2015
Q3 | $256K | Sell |
14,267
-8,257
| -37% | -$190K | 0.01% | 1054 |
|
|
2015
Q2 | $670K | Buy |
22,524
+2,267
| +11% | +$57K | 0.02% | 756 |
|
|
2015
Q1 | $446K | Buy |
20,257
+3,834
| +23% | +$97.3K | 0.01% | 916 |
|
|
2014
Q4 | $450K | Sell |
16,423
-700
| -4% | -$17K | 0.01% | 864 |
|
|
2014
Q3 | $332K | Buy |
+17,123
| New | +$314K | 0.01% | 1029 |
|
|
2013
Q3 | – | Sell |
-10,000
| Closed | -$139K | – | 1326 |
|
|
2013
Q2 | $139K | Buy |
+10,000
| New | +$109K | 0.01% | 1167 |
|
Other funds holding EXAS
Oppenheimer & Co's EXAS Position: Q3 2025 in Review
Oppenheimer & Co sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 22,365 shares — an estimated $1.19M sold.
Oppenheimer & Co first reported a position in EXAS in Q2 2013 and held it in 31 quarters. The position peaked at $3.04M in Q2 2021. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.
- Oppenheimer & Co reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
- Oppenheimer & Co sold 22,365 Exact Sciences shares in Q3 2025, an estimated $1.19M.
- Oppenheimer & Co first reported a position in Exact Sciences in Q2 2013 and held it in 31 quarters.
- Oppenheimer & Co's Exact Sciences position peaked at $3.04M in Q2 2021.
- 568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.
Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.